CAMX:STO
Camurus AB
SEKÂ 739.50
arrow_downward
-0.07%(-0.50) 1D
Nob 20, 5:29:43 PM GMT+1 · SEK
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CAMX...
Buksan
SEKÂ 738.50
Mataas
SEKÂ 745.50
Mababa
SEKÂ 733.50
Mkt. cap
44.78B
Avg. na dami
103.71K
Dami
71.53K
Mataas nang 52-wk
SEKÂ 750.00
Mababa nang 52-wk
SEKÂ 430.80
Mga natitirang share
60.56M
Bilang ng mga empleyado
323
Buksan
SEKÂ 738.50
Mataas
SEKÂ 745.50
Mababa
SEKÂ 733.50
Mkt. cap
44.78B
Avg. na dami
103.71K
Dami
71.53K
Mataas nang 52-wk
SEKÂ 750.00
Mababa nang 52-wk
SEKÂ 430.80
Mga natitirang share
60.56M
Bilang ng mga empleyado
323
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Fortune
·
1 oras ang nakalipas
Stock market correction? This chief investment officer sees the S&P 500 soaring 45% to 10,000
Nacionale
·
5 oras ang nakalipas
Is the S&P 500 in a bear market, and will it rally? No, it's in a correction, 11.6% below its record
Yahoo Finance
·
2 oras ang nakalipas
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
Beinsure
·
7 oras ang nakalipas
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Tungkol sa Camurus AB
CEOFredrik Tiberg
Mga Empleyado323
Itinatag1991
Headquarters-
SektorHealth Care
Industriya-
Websitecamurus.com